Recognition, Treatment and Complications of Meningococcal Disease

Author： Andrew F.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.1, Iss.4, 1999-10, pp. : 263-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complications of Serogroup B Meningococcal Disease in Survivors: A Review

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 14, Iss. 3, 2014-10 ,pp. : 205-212

Bentham Science Publishers

Access to resources Recommend Favorite

Meningococcal disease prevention in college students

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

New therapies and vaccines for meningococcal disease

By Carrol Enitan D   Thomson Alistair PJ   Hart C Anthony  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1487-1500

Informa Healthcare

Access to resources Recommend Favorite

Meningococcal Disease and Future Drug Targets

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 140-145

Bentham Science Publishers

Access to resources Recommend Favorite

Antibacterials still have primary role in meningococcal disease

By  

Inpharma, Vol. 1, Iss. 1287, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite